2024-08-22 / News

3SBio Unveils 2024 Interim Results: Revenue Up 16% YoY, Autoimmune Pipeline Poised for a Promising Phase

2024-03-20 / News

3SBio reveals 2023 annual results: Revenue surges by 13.8% year on year, with pipelines to reap the rewards

3SBio will remain steadfast in its role as a national biopharmaceutica...

2023-03-21 / News

3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%

3SBio is committed to sharpening its focus on refined management and e...